Dual MYC and GSPT1 Protein Degrader for MYC-Driven Cancers
Yuki Nishida(The University of Texas MD Anderson Cancer Center), Michael Andreeff(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
Mutant FLT3: A Direct Target of Sorafenib in Acute Myelogenous Leukemia
|JNCI Journal of the National Cancer Institute|2008|338
Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment
|Blood|2012|140
The Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid Induces Caspase-Dependent and -Independent Apoptosis in Acute Myelogenous Leukemia
|Cancer Research|2004|135
2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) Directly Targets Mitochondrial Glutathione to Induce Apoptosis in Pancreatic Cancer
|Journal of Biological Chemistry|2005|104